logo
Vuzix Achieves Waveguide Production and Yield Targets and Receives $5 Million Second Tranche Investment from Quanta Computer

Vuzix Achieves Waveguide Production and Yield Targets and Receives $5 Million Second Tranche Investment from Quanta Computer

Yahoo7 hours ago

ROCHESTER, N.Y., June 16, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or the "Company"), a leading supplier of AI-powered smart glasses, advanced waveguides, and augmented reality (AR) technologies, today announced the receipt of a $5 million second tranche investment from Quanta Computer (TWSE: 2382), a premier global ODM and strategic partner. This latest investment brings Quanta's total investment in Vuzix to $15 million out of an anticipated total of $20 million, as previously announced on September 3, 2024.
"The completion of this second tranche investment marks another important milestone in strengthening our partnership with Quanta and expanding the capabilities of our cutting-edge waveguide production facility," said Paul Travers, President and CEO of Vuzix. "With this funding, we are further enhancing our state-of-the-art waveguide manufacturing capabilities, positioning Vuzix to deliver the world's most affordable, lightweight, and performance-driven AI smart glasses for mass-market adoption. We are excited about the continued collaboration and innovation ahead with a partner as respected as Quanta."
The foregoing description of Quanta's investment is qualified in its entirety by reference to the Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 16, 2025.
About Vuzix Corporation
Vuzix is a leading designer, manufacturer and marketer of AI-powered Smart Glasses, Waveguides and Augmented Reality (AR) technologies, components and products for the enterprise, medical, defense and consumer markets. The Company's products include head-mounted smart personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality, as well OEM waveguide optical components and display engines. Vuzix holds more than 425 patents and patents pending and numerous IP licenses in the fields of optics, head-mounted displays, and the augmented reality wearables field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2024 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in: Rochester, NY; and Kyoto and Okayama, Japan. For more information, visit the Vuzix website, X and Facebook pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward-looking statements contained in this release include, without limitation, statements that relate to potential impact of investments, the completion of the third investment tranche, Vuzix Smart Glasses, our business relationship and future business opportunities with Quanta Computer and their customers and the Company's leadership in the Smart Glasses and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the "Risk Factors" and MD&A sections of the Company's Annual Reports and other filings with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
Vuzix Media and Investor Relations Contact:
Ed McGregor, Director of Investor Relations,Vuzix Corporationed_mcgregor@vuzix.com Tel: (585) 359-5985
Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,Investor Information – IR@vuzix.com www.vuzix.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vuzix-achieves-waveguide-production-and-yield-targets-and-receives-5-million-second-tranche-investment-from-quanta-computer-302482070.html
SOURCE Vuzix Corporation

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating
Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating

Yahoo

timean hour ago

  • Yahoo

Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating

Disc Medicine, Inc. (NASDAQ:IRON) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 11, analysts from Raymond James resumed coverage of Disc Medicine, Inc. (NASDAQ:IRON) with a strong Buy rating and a price target of $89. The resumed coverage comes as the company released its research note on Biotech names. The firm highlighted a favorable risk/reward profile in the biotech sector. It noted that while companies with a high probability of success for lead assets inspire higher conviction, investments in less de-risked assets like Disc Medicine, Inc. (NASDAQ:IRON) could yield the most outsized returns. The firm sees more than $1 billion potential for the company's drug bitopertin, with an expected market penetration of about 30%-35%, owing to its disease-modifying agent capabilities X-linked protoporphyria. A scientist in a laboratory setting examining a sample of blood with a microscope. Disc Medicine, Inc. (NASDAQ:IRON) is a clinical-stage biopharmaceutical company focused on discovering therapies for serious hematologic diseases. Its pipeline includes drug candidates like bitopertin for erythropoietic porphyrias and Diamond-Blackfan Anemia, DISC-0974 for anemia related to myelofibrosis and chronic kidney disease, and DISC-3405 for polycythemia vera and other blood disorders. While we acknowledge the potential of IRON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

Sabre Corporation (SABR) Announces Signing a 5-Year Renewal Agreement with Vietravel Airlines
Sabre Corporation (SABR) Announces Signing a 5-Year Renewal Agreement with Vietravel Airlines

Yahoo

timean hour ago

  • Yahoo

Sabre Corporation (SABR) Announces Signing a 5-Year Renewal Agreement with Vietravel Airlines

Sabre Corporation (NASDAQ:SABR) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 9, Sabre Corporation (NASDAQ:SABR) announced signing a 5-year renewal agreement with Vietravel Airlines to continue allowing the airline to use Sabre's Radixx Passenger Service System. The PSS is a cloud-based platform that offers end-to-end retailing, passenger servicing, and operational capabilities tailored for airlines. Vietravel Airlines will continue using the full suite of the solution that includes Radixx Res, Radixx EzyCommerce, Radixx Go, and Radixx Insight. This technology suite allows Vietravel Airlines to enhance passenger experience, scale operations efficiently, and access new revenue streams through Global Distribution System channels. This renewal is a testament to the strength and value of the Radixx platform, said Nico Stoman, Head of Radixx Sales and Account Management of Sabre Corporation (NASDAQ:SABR). An international traveler consulting the company's app on their smartphone, illustrating their successful online marketplace. Sabre Corporation (NASDAQ:SABR) is a leading global technology company that powers the travel industry by providing advanced software solutions to airlines, hotels, travel agencies, and other travel partners. Its services include global distribution systems that connect travel suppliers with sellers in real-time. The company ranks as one of the best small-cap growth stocks to buy according to analysts. While we acknowledge the potential of SABR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

Qualcomm Acquires Alphawave for $2.4B to Expand AI Data Center Footprint
Qualcomm Acquires Alphawave for $2.4B to Expand AI Data Center Footprint

Yahoo

timean hour ago

  • Yahoo

Qualcomm Acquires Alphawave for $2.4B to Expand AI Data Center Footprint

Qualcomm Incorporated (NASDAQ:QCOM) is one of the 8 cheap beginner stocks to buy right now. On June 9, Qualcomm Incorporated (NASDAQ:QCOM), which is growing into the rapidly expanding AI data center industry, agreed to buy Alphawave for approximately $2.4 billion. While Apple ranks as one of Qualcomm's key customers, the iPhone manufacturer's increasing uses of in-house processors has led to the semiconductor company to expand its focus on serving industries like data centers and personal computers. Kārlis Dambrāns/Flickr The same day, Qualcomm Incorporated (NASDAQ:QCOM) also made two other all-share proposals for Alphawave. However, Alphawave intends to unanimously recommend the offer to its investors, believing it to be reasonable and fair. Jefferies analysts stated that given Alphawave's exit from its Chinese joint venture, WiseWave, they do not anticipate any significant regulatory barriers to the sale. The deal is expected to close in Q1, 2026 depending on regulatory approvals. In a statement regarding this acquisition, Cristiano Amon, president and CEO of Qualcomm, said the following: 'Qualcomm's advanced custom processors are a natural fit for data center workloads. The combined teams share the goal of building advanced technology solutions and enabling next-level connected computing performance across a wide array of high growth areas, including data center infrastructure.' QUALCOMM Incorporated (NASDAQ:QCOM) is a well-known American manufacturer of semiconductors and telecom equipment. The company supplies chips to major companies in a number of high-growth industries, including smartphones and autonomous vehicles. While we acknowledge the potential of QCOM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store